Christopher Y. Chai, Chief Financial Officer at MAP Pharmaceuticals, Inc. (MAPP), sold 16,000 shares at $14.05 ($225K) on 2010-09-20, disclosed to the SEC on 2010-09-22.
Scheduled sale ($225k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRNB | SELL | 2020-02-20 | $818K | — | Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-07-22 | $203K | — | Filing → |